Ardent Health Partners Inc (NYSE: ARDT) has a price-to-earnings ratio that is above its average at 8.49x. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ARDT is 22.46M, and at present, short sellers hold a 5.75% of that float. On April 18, 2025, the average trading volume of ARDT was 486.39K shares.
ARDT) stock’s latest price update
The stock price of Ardent Health Partners Inc (NYSE: ARDT) has surged by 1.71 when compared to previous closing price of 12.30, but the company has seen a 3.30% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-04-03 that BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 20.
ARDT’s Market Performance
Ardent Health Partners Inc (ARDT) has experienced a 3.30% rise in stock performance for the past week, with a -11.96% drop in the past month, and a -9.35% drop in the past quarter. The volatility ratio for the week is 4.16%, and the volatility levels for the past 30 days are at 4.86% for ARDT. The simple moving average for the last 20 days is -1.30% for ARDT stock, with a simple moving average of -22.85% for the last 200 days.
Analysts’ Opinion of ARDT
Many brokerage firms have already submitted their reports for ARDT stocks, with JP Morgan repeating the rating for ARDT by listing it as a “Neutral.” The predicted price for ARDT in the upcoming period, according to JP Morgan is $20 based on the research report published on December 17, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ARDT reach a price target of $19, previously predicting the price at $22. The rating they have provided for ARDT stocks is “Neutral” according to the report published on November 06th, 2024.
KeyBanc Capital Markets gave a rating of “Overweight” to ARDT, setting the target price at $24 in the report published on October 11th of the previous year.
ARDT Trading at -9.11% from the 50-Day Moving Average
After a stumble in the market that brought ARDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.62% of loss for the given period.
Volatility was left at 4.86%, however, over the last 30 days, the volatility rate increased by 4.16%, as shares sank -10.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.04% lower at present.
During the last 5 trading sessions, ARDT rose by +3.30%, in comparison to the 20-day moving average, which settled at $12.67. In addition, Ardent Health Partners Inc saw -26.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARDT starting from Webb Robert Thomas, who purchase 20,000 shares at the price of $16.98 back on Nov 08 ’24. After this action, Webb Robert Thomas now owns 40,275 shares of Ardent Health Partners Inc, valued at $339,600 using the latest closing price.
Stock Fundamentals for ARDT
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.73 for the gross margin
The net margin for Ardent Health Partners Inc stands at 0.04. The total capital return value is set at 0.03. Equity return is now at value 23.34, with 4.03 for asset returns.
Based on Ardent Health Partners Inc (ARDT), the company’s capital structure generated 1.0 points at debt to capital in total, while cash flow to debt ratio is standing at 0.14.
Currently, EBITDA for the company is 574.93 million with net debt to EBITDA at 3.02. When we switch over and look at the enterprise to sales, we see a ratio of 0.59. The receivables turnover for the company is 8.03for trailing twelve months and the total asset turnover is 1.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.94.
Conclusion
To sum up, Ardent Health Partners Inc (ARDT) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
